FOLH1 and cancer: In particular, there are a number of aptamers reported in the literature that putatively bind therapeutically relevant cancer markers including: the prostate specific membrane antigen (PSMA)10–12, human transferrin receptor (hTfR)13,14, the epidermal growth factor receptor (EGFR)15–17, and others18–23.